Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets meet to resolve isoflurane supply problem
Isoflurane is one of the most commonly-used veterinary anaesthetic agents.

Special manufacturer to partially fill gap in supply 

A solution to the temporary isoflurane supply problem has been reached by the VMD following discussion with the BEVA, BSAVA and the AVA.

According to a press release, one special manufacturer is intending to produce isoflurane to fill or partially fill the gap in supply, which should be available in around three to four weeks time.

One of the most commonly-used veterinary anaesthetic agents, the production of isoflurane was temporarily ceased last week due to a mechanical problem on the production line. With limited stocks of alternative products - and the potential for supply to be restricted - clinics raised concern they would not be able to perform emergency surgery over the Christmas period.

Having looked into alternative sources of isoflurane, the BEVA, BSVA and the AVA put forward ways the VMD might be able to alleviate the risks to animal welfare.

In a press release, the organisations said the VMD ‘responded rapidly and positively’. David Rendle, a member of BEVA’s Health and Medicines Committee, said:

“BEVA has a close relationship with the veterinary pharmaceutical industry and will always work swiftly and collaboratively to help develop practical solutions to supply problems for our members.”

BSAVA President Philip Lhermette praised the VMD for such prompt action. He said: “The VMD listened to our concerns and acted immediately. By doing so they have addressed and helped to prevent any potential welfare risks associated with a lack of isoflurane.”  

Carl Bradbrook, AVA junior vice president, reminded clinicians to “seek advice when considering the use of unfamiliar anaesthetic protocols.”

The associations stressed that the situation doesn’t give vets free rein to ignore the medicines legislation. 'The cascade must still be followed, and client informed consent obtained if an unregulated anaesthetic is used', they said. 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.